SEK 0.07
+0.01 (+13.19%)
SEK · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where EPIS-B.ST is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional · 1 observational
government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Episealer® Knee System IDE Clinical StudyNCT04000659Change in the Knee Injury & Osteoarthritis Outcome Score (KOOS) SubscoresRandomized · Single-masked · Treatment | Not applicable | Active, not recruiting | Device: Episealer Knee System · Procedure: Microfracture | Degenerative Lesion of Articular Cartilage of Knee | 13 | Jun 2026 | 2024-07-30 |
| Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral DefectsNCT06225674observationalAssessment of total SEFAS (self-reported foot and ankle score) outcome | — | Unknown status | Device: Episealer Talus implant | Osteochondral Defect | 25 | 2024-03-06 | 2024-01-26 |
| Investigation of a Customized Femoral Resurfacing ImplantNCT01690689Number of participants with Adverse EventsOpen-label · Treatment | Not applicable | Completed | Device: Implant surgery | Articular Cartilage Disorder | 10 | 2017-03-31actual | 2020-12-17 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19